Macron and African Leaders Launch $1 Billion Vaccine Manufacturing Push

French President Emmanuel Macron, along with several African leaders, inaugurated a $1 billion initiative to accelerate vaccine manufacturing in Africa. The African Vaccine Manufacturing Accelerator aims to address vaccine access inequalities exposed by COVID-19, improve pandemic preparedness, and boost Africa's vaccine production capacity to 60% by 2040.

French President Emmanuel Macron joined forces with several African leaders on Thursday to inaugurate a $1 billion initiative aimed at accelerating the production of vaccines in Africa. This strategic move comes in the wake of glaring inequalities exposed during the coronavirus pandemic, particularly in vaccine accessibility.

The African Vaccine Manufacturing Accelerator, designed to offer financial incentives to vaccine manufacturers, provided Macron with a brief respite from his domestic political challenges ahead of the legislative election on June 30 and July 7. Macron emphasized that Africa, producing only 2% of the vaccines it uses, needs to reach a target of 60% by 2040. France and Europe have supported this ambition with a 1.3 billion euros allocation since 2021, and efforts to accelerate this goal are underway.

The event also aimed to boost funding for Gavi, the Vaccine Alliance, which is committed to making up to $1 billion available over the next decade to enhance Africa's manufacturing capacity, improve global vaccine markets, and bolster pandemic preparedness for diseases such as HIV, malaria, tuberculosis, and COVID-19. Officials are also looking at issues like technology transfer and the creation of a potential African medicines agency to streamline regulatory processes.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)